Plasma lipid analysis revealed elevated ceramide levels in patients with SPTLC2‐ALS compared to healthy individuals, indicating increased serine palmitoyltransferase (SPT) activity. Here, SPTLC2 is linked to amyotrophic lateral sclerosis.